Jasper Hellweg
Stock Analyst at Argus Research
(4.14)
# 1,590
Out of 4,581 analysts
234
Total ratings
56.5%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVS Novartis AG | Maintained: Buy | $160 → $170 | $158.83 | +7.03% | 3 | Jul 24, 2026 | |
| BIIB Biogen | Maintained: Hold | n/a | $209.23 | - | 6 | Jul 10, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 69.57 | CHF 57.14 | +21.76% | 5 | Jul 1, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | n/a | $26.39 | - | 7 | Jun 23, 2026 | |
| GSK GSK plc | Maintained: Buy | n/a | $53.22 | - | 2 | Jun 8, 2026 | |
| ZTS Zoetis | Downgraded: Hold | n/a | $77.93 | - | 12 | May 26, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $220 → $250 | $263.30 | -5.05% | 5 | May 13, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $130 | $130.36 | -0.28% | 5 | May 8, 2026 | |
| RHHBY Roche Holding AG | Upgraded: Buy | $55 | $54.97 | +0.05% | 3 | Apr 6, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | n/a | $51.58 | - | 7 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $345 → $560 | $524.70 | +6.73% | 11 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $54.49 | - | 14 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $63.10 | - | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $695.42 | n/a | 13 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $132.73 | n/a | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $100 | $194.82 | n/a | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $24.77 | n/a | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $34.71 | n/a | 9 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,210.02 | n/a | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $17.82 | n/a | 4 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $360 | $387.64 | n/a | 6 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $60 | $44.85 | n/a | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $465 → $550 | $483.33 | n/a | 11 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $125 | $99.82 | n/a | 8 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $70 | $127.10 | n/a | 6 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 | $5.00 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $285 → $225 | $187.05 | n/a | 6 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $307.15 | n/a | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $165 | $235.22 | n/a | 6 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $475 → $500 | $375.98 | n/a | 5 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $290 | $247.56 | n/a | 5 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 → $275 | $408.18 | n/a | 6 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $50 | $46.04 | n/a | 3 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.35 | n/a | 5 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $135 | $106.99 | n/a | 5 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $115 | $55.63 | n/a | 4 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.43 | n/a | 3 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $288.01 | n/a | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $55.86 | n/a | 1 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $24.44 | n/a | 2 | Aug 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $199.24 | n/a | 1 | Aug 31, 2016 |
Novartis AG
Jul 24, 2026
Maintained: Buy
Price Target: $160 → $170
Current: $158.83
Upside: +7.03%
Biogen
Jul 10, 2026
Maintained: Hold
Price Target: n/a
Current: $209.23
Upside: -
Alcon Inc.
Jul 1, 2026
Maintained: Buy
Price Target: CHF 69.57
Current: CHF 57.14
Upside: +21.76%
Elanco Animal Health
Jun 23, 2026
Maintained: Buy
Price Target: n/a
Current: $26.39
Upside: -
GSK plc
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $53.22
Upside: -
Zoetis
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $77.93
Upside: -
AbbVie
May 13, 2026
Reiterated: Buy
Price Target: $220 → $250
Current: $263.30
Upside: -5.05%
Merck & Co.
May 8, 2026
Reiterated: Buy
Price Target: $130
Current: $130.36
Upside: -0.28%
Roche Holding AG
Apr 6, 2026
Upgraded: Buy
Price Target: $55
Current: $54.97
Upside: +0.05%
Novo Nordisk
Mar 20, 2026
Maintained: Hold
Price Target: n/a
Current: $51.58
Upside: -
Mar 3, 2026
Rated: Buy
Price Target: $345 → $560
Current: $524.70
Upside: +6.73%
Jan 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $54.49
Upside: -
Jan 7, 2026
Maintained: Hold
Price Target: n/a
Current: $63.10
Upside: -
Jun 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $695.42
Upside: n/a
May 5, 2025
Reiterated: Buy
Price Target: $100 → $120
Current: $132.73
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $150 → $100
Current: $194.82
Upside: n/a
Feb 24, 2025
Upgraded: Buy
Price Target: $40
Current: $24.77
Upside: n/a
Jan 30, 2025
Maintained: Buy
Price Target: $20
Current: $34.71
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: n/a
Current: $1,210.02
Upside: n/a
Jan 6, 2025
Maintained: Hold
Price Target: n/a
Current: $17.82
Upside: n/a
Aug 20, 2024
Maintained: Buy
Price Target: $340 → $360
Current: $387.64
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $55 → $60
Current: $44.85
Upside: n/a
Jun 17, 2024
Maintained: Buy
Price Target: $465 → $550
Current: $483.33
Upside: n/a
Apr 29, 2024
Maintained: Buy
Price Target: $105 → $125
Current: $99.82
Upside: n/a
Apr 25, 2024
Maintained: Buy
Price Target: $90 → $70
Current: $127.10
Upside: n/a
Dec 7, 2022
Upgraded: Buy
Price Target: $26
Current: $5.00
Upside: n/a
Oct 24, 2022
Maintained: Buy
Price Target: $285 → $225
Current: $187.05
Upside: n/a
Sep 19, 2022
Downgraded: Hold
Price Target: n/a
Current: $307.15
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $135 → $165
Current: $235.22
Upside: n/a
Feb 7, 2022
Maintained: Buy
Price Target: $475 → $500
Current: $375.98
Upside: n/a
Sep 10, 2021
Maintained: Buy
Price Target: $260 → $290
Current: $247.56
Upside: n/a
Aug 2, 2021
Maintained: Buy
Price Target: $195 → $275
Current: $408.18
Upside: n/a
Jun 7, 2021
Maintained: Buy
Price Target: $43 → $50
Current: $46.04
Upside: n/a
May 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $7.35
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $95 → $135
Current: $106.99
Upside: n/a
Jun 12, 2020
Maintained: Buy
Price Target: $135 → $115
Current: $55.63
Upside: n/a
Apr 17, 2020
Downgraded: Hold
Price Target: n/a
Current: $10.43
Upside: n/a
Mar 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $288.01
Upside: n/a
Oct 30, 2019
Downgraded: Hold
Price Target: n/a
Current: $55.86
Upside: n/a
Aug 15, 2019
Upgraded: Buy
Price Target: $40
Current: $24.44
Upside: n/a
Aug 31, 2016
Downgraded: Hold
Price Target: n/a
Current: $199.24
Upside: n/a